{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:20:09Z","timestamp":1791235209853,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Governo Italiano Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.numecd.2024.08.016","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T06:33:11Z","timestamp":1724826791000},"page":"103723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Do genetically determined very high and very low LDL levels contribute to Lp(a) plasma concentration?"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3088-3049","authenticated-orcid":false,"given":"Antonina","family":"Giammanco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5346-2829","authenticated-orcid":false,"given":"Davide","family":"Noto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-0285","authenticated-orcid":false,"given":"Emilio","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola Maria","family":"Gagliardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Scrimali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Brucato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4114-038X","authenticated-orcid":false,"given":"Carlo Maria","family":"Barbagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Caldarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Ciaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Baldassare","family":"Cefal\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3558-9209","authenticated-orcid":false,"given":"Maurizio","family":"Averna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.numecd.2024.08.016_bib1","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.jacl.2022.08.007","article-title":"Use of Lipoprotein(a) in clinical practice: a biomarker whose time has come. A scientific statement from the National Lipid Association","volume":"16","author":"Wilson","year":"2022","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.numecd.2024.08.016_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2022.04.005","article-title":"Lipoprotein(a) and ethnicities","volume":"349","author":"Mehta","year":"2022","journal-title":"Atherosclerosis"},{"issue":"23","key":"10.1016\/j.numecd.2024.08.016_bib3","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2024.08.016_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2022.04.015","article-title":"Lipoprotein(a) and cardiovascular and valvular diseases: a genetic epidemiological perspective","volume":"349","author":"Arsenault","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2024.08.016_bib5","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J Lipid Res"},{"issue":"24","key":"10.1016\/j.numecd.2024.08.016_bib6","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/eurheartj\/ehaa552","article-title":"The next chapter of prevention: from LDL-cholesterol to lipoprotein(a) and triglycerides","volume":"41","author":"Luscher","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2024.08.016_bib7","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/0140-6736(90)91242-3","article-title":"Apolipoprotein(A) and ischaemic heart disease in familial hypercholesterolaemia","volume":"335","author":"Wiklund","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2024.08.016_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI115329","article-title":"Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro 664>le mutation in the LDL-receptor gene","volume":"88","author":"Soutar","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2024.08.016_bib9","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.ATV.15.12.2165","article-title":"Familial hypobetalipoproteinemia is not associated with low levels of lipoprotein(a)","volume":"15","author":"Averna","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2024.08.016_bib10","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM199005243222104","article-title":"Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia","volume":"322","author":"Seed","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2024.08.016_bib11","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/01.ATV.11.4.940","article-title":"Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations","volume":"11","author":"Mbewu","year":"1991","journal-title":"Arterioscler Thromb"},{"issue":"4","key":"10.1016\/j.numecd.2024.08.016_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MOL.0000000000000839","article-title":"Lipoprotein (a) in familial hypercholesterolaemia","volume":"33","author":"Durrington","year":"2022","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"10.1016\/j.numecd.2024.08.016_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.numecd.2024.08.016_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2007.03.005","article-title":"The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population","volume":"197","author":"Noto","year":"2008","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.numecd.2024.08.016_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/sj.ijo.0801321","article-title":"Prevalence of overweight and obesity in a rural Southern Italy population and relationships with total and cardiovascular mortality: the Ventimiglia di Sicilia project","volume":"25","author":"Barbagallo","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"5","key":"10.1016\/j.numecd.2024.08.016_bib16","first-page":"226","article-title":"Enzymatic determination of total cholesterol in serum","volume":"12","author":"Roeschlau","year":"1974","journal-title":"Z Klin Chem Klin Biochem"},{"key":"10.1016\/j.numecd.2024.08.016_bib17","series-title":"Methods of enzymatic analysis","first-page":"1831","article-title":"Determination of serum triglycerides level","author":"Wahlefeld","year":"1974"},{"key":"10.1016\/j.numecd.2024.08.016_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2024.08.016_bib19","series-title":"Genetics of coronary Heart disease","first-page":"75","article-title":"Potential significance of Lp (a) lipoprotein clinical methodological aspects","author":"Dahlen","year":"1992"},{"issue":"10","key":"10.1016\/j.numecd.2024.08.016_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029223","article-title":"Lipoprotein(a) genotype influences the clinical diagnosis of familial hypercholesterolemia","volume":"12","author":"Olmastroni","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2024.08.016_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100053","article-title":"Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements","volume":"62","author":"Yeang","year":"2021","journal-title":"J Lipid Res"},{"issue":"24","key":"10.1016\/j.numecd.2024.08.016_bib22","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2024.08.016_bib23","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2024.08.016_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2017.03.021","article-title":"Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease","volume":"260","author":"Li","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2024.08.016_bib25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s10545-007-0585-z","article-title":"Hyperlipoproteinaemia(a) is a common cause of autosomal dominant hypercholesterolaemia","volume":"30","author":"Meri\u02dcno-Ibarra","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.numecd.2024.08.016_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jacl.2017.02.010","article-title":"Plasma lipoprotein(a) levels in patients with homozygous autosomal dominant hypercholesterolemia","volume":"11","author":"Sjouke","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.numecd.2024.08.016_bib27","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2024.08.016_bib28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1253\/circj.CJ-15-0999","article-title":"Lipoprotein(a) in familial hypercholesterolemia with proprotein convertase subtilisin\/kexin type 9 (PCSK9) gain-of-function mutations","volume":"80","author":"Tada","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.numecd.2024.08.016_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-8587(16)30042-0","article-title":"High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study","volume":"4","author":"Langsted","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.numecd.2024.08.016_bib30","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.jacc.2020.03.065","article-title":"Ascertainment bias in the association between elevated lipoprotein(a) and familial hypercholesterolemia","volume":"75","author":"Trinder","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2024.08.016_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.atherosclerosis.2018.08.011","article-title":"Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin\/kexin type 9 levels in patients with potential familial hypercholesterolemia","volume":"277","author":"Afanasieva","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2024.08.016_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.ATV.16.1.129","article-title":"Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect","volume":"16","author":"Carmena","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2024.08.016_bib33","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1073\/pnas.86.11.4171","article-title":"Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis","volume":"86","author":"Utermann","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.numecd.2024.08.016_bib34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-2275(20)42831-7","article-title":"Rhesus monkey model of familial hypercholesterolemia: relation between plasma Lp[a] levels, apo[a] isoforms, and LDL-receptorfunction","volume":"31","author":"Neven","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2024.08.016_bib35","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1172\/JCI117794","article-title":"The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans","volume":"95","author":"Rader","year":"1995","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.numecd.2024.08.016_bib36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","article-title":"Lipoprotein(a): resurrected by genetics","volume":"273","author":"Kronenberg","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/j.numecd.2024.08.016_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2022-002060","article-title":"Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease","volume":"9","author":"Nissen","year":"2022","journal-title":"Open Heart"},{"issue":"39","key":"10.1016\/j.numecd.2024.08.016_bib38","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1093\/eurheartj\/ehad472","article-title":"Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society","volume":"44","author":"van Lennep","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2024.08.016_bib39","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jacc.2012.12.023","article-title":"Extreme lipoprotein(a) levels and improved cardiovascular risk prediction","volume":"61","author":"Kamstrup","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2024.08.016_bib40","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jacc.2014.03.061","article-title":"Discrimination and net reclassification of cardiovascular risk with lipoprotein (a): prospective 15-year outcomes in the Bruneck study","volume":"64","author":"Willeit","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2024.08.016_bib41","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1177\/2047487320938271","article-title":"Use of lipoprotein(a) for refining cardiovascular risk prediction in a low-risk population: the CoLaus\/PsyCoLaus study","volume":"28","author":"Delabays","year":"2021","journal-title":"Eur J Prev Cardiol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324003260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324003260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T12:12:39Z","timestamp":1738930359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475324003260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0939475324003260"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2024.08.016","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do genetically determined very high and very low LDL levels contribute to Lp(a) plasma concentration?","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2024.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}],"article-number":"103723"}}